Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pioneering needle-free disease monitoring
Symbiome offers skincare as nature intended solution which is scientifically and intentionally formulated using ancestral ingredients.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.
Alessa Therapeutics develops localized treatments for solid organ disease.
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.
Integrated Biosciences develops next-generation therapeutics.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
INVENIO IMAGING is a privately held corporation
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Arkuda Therapeutics is a pharmaceutical company.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Mission BioCapital has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Mission BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 19 different industry categories.
Among tracked funding rounds, Tune Therapeutics received $175.0M in a Series B round. Mission BioCapital's total known invested capital is $1.8B.
Mission BioCapital's average investment size is $43.2M across its portfolio of 62 companies.
Recent Mission BioCapital portfolio additions include GraphWear Technologies, Symbiome, Enodia Therapeutics, EpiBiologics, Nocion Therapeutics. These companies were founded in 2020 or later.